Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
538.00    -8.00 (-1.47%)
Bid:
539.00
Ask:
540.00
Spread: 1.00 (0.186%)
Market Cap: £531.26m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

COVID-19 Update

31 Mar 2020 07:00

RNS Number : 1332I
Galliford Try Holdings PLC
31 March 2020
 

GALLIFORD TRY HOLDINGS PLC

COVID-19 UPDATE

31 MARCH 2020

 

Galliford Try, one of the UK's leading construction groups, provides an operational update on the impact of the Covid-19 pandemic on its business and the measures it is taking in response.

The health and safety of our staff, subcontractors, suppliers, clients and the public is paramount, and in compliance with Government guidance we are implementing additional measures to protect and mitigate risk.

Management response

Across the Group we are working with the NHS and others to assist and support them to increase capacity to meet the current challenges and immediate needs.

In accordance with Government advice on construction works and the Standard Operating Procedures issued by the Construction Leadership Council, we have risk assessed every one of our construction sites and modified or curtailed site activities to ensure that no work is undertaken if we are unable to fully comply with the hygiene and social distancing guidelines or if our people cannot travel safely to work. Sites that remain operating do so under the strictest of parameters, as set out by the Construction Leadership Council, in conjunction with our own rigorous risk assessments. In addition, where specific client instructions have been received, we are carefully managing temporary closure of sites to leave them in a safe state whilst they are closed.

Where projects are temporarily suspended, we are planning for the speedy resumption of works as soon as conditions allow. We are continuing to monitor the situation and liaise with our clients, and support our supply chain, on all projects.

We have already taken a number of actions to manage costs in the business and conserve cash, and we will continue to review our resources to match business requirements. The business expects to make use of the Government Coronavirus Job Retention Scheme and other measures announced by the Government in response to the pandemic. The Group is committed to fully supporting all staff and has implemented furloughing of personnel where appropriate.

The scale and duration of disruption to our activities, and the impact on our supply chain, is not yet clear. For this reason, it is too early to quantify the potential impact of Covid-19 on revenue and operating profit, and hence it is not possible at the present time to provide guidance for our financial years ending 30 June 2020 and 30 June 2021.

Balance sheet and dividend

Galliford Try remains a well-capitalised business with no debt or bank covenants. The Government is continuing to support our sector, for example through the Cabinet Office Procurement Policy Note which provides guidance on payment by public bodies during the Covid-19 outbreak, and 83% of our order book is in the public and regulated sectors. The Group's cash levels remain in line with management's expectations, with average month end cash for the second half of the financial year to 30 June 2020 expected to remain over £100m, and the Group continues to hold a PPP portfolio of £39m. The Group is implementing additional measures, including the furloughing of personnel referred to above, to manage its working capital and preserve its liquidity through this period of disruption. The Board is continuing to monitor developments closely and is confident that the Group is well placed to withstand the current period of uncertainty and positioned to deliver as the market recovers. In the prevailing circumstances the Board considers it prudent to cancel payment of the interim dividend of 1.0p per share announced on 12 March 2020. The Board will at the appropriate time consider paying the interim dividend with the final dividend.

 

Bill Hocking, Chief Executive of Galliford Try, commented: "These are extremely challenging times and our upmost priority remains the health and safety of our employees and the wider community. We are a well-capitalised business, taking all necessary steps through the present circumstances to ensure that we are well placed to support economic recovery."

 

 

For further enquiries please contact:

 

 

Galliford Try:

Bill Hocking, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

01895 855001

Tulchan Communications:

James Macey White, Giles Kernick, Amber Ahluwalia

 

0207 353 4200

 

 

 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBBLLXBXLXBBX
Date   Source Headline
21st Sep 20183:18 pmRNSDirector/PDMR Shareholding
21st Sep 20183:11 pmRNSDirector/PDMR Shareholding
18th Sep 20183:30 pmRNSHolding(s) in Company
17th Sep 20183:00 pmRNSHolding(s) in Company
12th Sep 20187:00 amRNSFinal Results
4th Sep 201810:00 amRNSHolding(s) in Company
3rd Sep 20189:00 amRNSConfirmation of Directorate Change
21st Aug 201812:00 pmRNSHolding(s) in Company
1st Aug 20182:00 pmRNSTotal Voting Rights
24th Jul 20184:00 pmRNSHolding(s) in Company
19th Jul 201811:00 amRNSDirectorate Change
17th Jul 20187:00 amRNSTrading Statement
11th Jul 201812:00 pmRNSHolding(s) in Company
2nd Jul 201812:00 pmRNSTotal Voting Rights
27th Jun 20182:00 pmRNSBlock listing Interim Review
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
5th Jun 20182:00 pmRNSDirector/PDMR Shareholding
1st Jun 201812:00 pmRNSTotal Voting Rights
25th May 201812:00 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSTrading Statement
9th May 20184:00 pmRNSHolding(s) in Company
1st May 20184:00 pmRNSTotal Voting Rights
18th Apr 201812:00 pmRNSTotal Voting Rights
16th Apr 20183:15 pmRNSDirector/PDMR Shareholding
16th Apr 20182:43 pmRNSSuccessful Placing of Rights Issue Rump
16th Apr 20188:15 amRNSTotal Voting Rights
16th Apr 20187:25 amRNSResults of Rights Issue
9th Apr 20184:30 pmRNSDirector/PDMR Shareholding
6th Apr 20184:30 pmRNSHolding(s) in Company
6th Apr 201810:00 amRNSHolding(s) in Company
5th Apr 201810:30 amRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 201811:00 amRNSHolding(s) in Company
3rd Apr 201811:00 amRNSTotal Voting Rights
28th Mar 20182:30 pmRNSDirector/PDMR Shareholding
28th Mar 201811:00 amRNSDirector/PDMR Shareholding
27th Mar 20181:11 pmRNSPublication of Prospectus
27th Mar 20187:00 amRNSAnnouncement re: Rights Issue
20th Mar 201810:00 amRNSHolding(s) in Company
1st Mar 201812:00 pmRNSTotal Voting Rights
1st Mar 201810:00 amRNSHolding(s) in Company
14th Feb 20187:00 amRNSFully Underwritten £150 million Capital Raising
14th Feb 20187:00 amRNSHalf-year Report
5th Feb 201810:00 amRNSHolding(s) in Company
1st Feb 201812:00 pmRNSTotal Voting Rights
15th Jan 201811:04 amRNSJoint Venture with Carillion plc
2nd Jan 201812:00 pmRNSTotal Voting Rights
5th Dec 20173:00 pmRNSBlock Listing Application
4th Dec 201710:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.